Back to mobile site

Cosette Pharmaceuticals acquires SYMPAZAN and six other branded drugs

April 8, 2026 4:10 PM EDT Send to a Friend
Cosette Pharmaceuticals announced the completion of its acquisition of U.S. sales and distribution rights for seven branded pharmaceutical products from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login